• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Finance

Finance

BiomeSense Raises $2 Million in Seed Round Funding

October 11, 2019 Microbiome Times

BiomeSense, a microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, announced today that it has closed its $2 million seed funding round. The lead investor was BioX Clan, which […]

Animal Health

Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019

October 10, 2019 Microbiome Times

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health for Life investments for the period July 2019 to […]

Finance

BASF and Biomillenia join forces in microbiome research to promote healthy skin

October 8, 2019 Microbiome Times

BASF and Biomillenia today announced the signing of a microbiome discovery agreement. The collaboration aims to identify novel dermocosmetic active ingredients involved in promoting skin health. The French company Biomillenia will contribute its unique microbiome-on-a-chip […]

Finance

4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines

October 8, 2019 Microbiome Times

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces that the Company has entered into a research collaboration and option to license agreement with MSD, the tradename of […]

Finance

Evolve BioSystems Jointly Files Patent Infringement Complaint Against Abbott Laboratories

October 1, 2019 Microbiome Times

Evolve BioSystems and the Regents of the University of California have jointly filed and served a patent infringement complaint against Abbott Laboratories. The complaint regards Abbott’s soon-to-be-launched product Similac Probiotic Tri-Blend. Evolve BioSystems was founded […]

Finance

Vedanta Biosciences Announces $16.6 Million Series C-2 Financing

September 24, 2019 Microbiome Times

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced a $16.6 million Series C-2 financing round, bringing the total capital […]

Finance

Indigo Opens European Headquarters in Switzerland leading the transition to a more beneficial agriculture system in Europe

September 16, 2019 Microbiome Times

Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces its expansion into Europe and opens its headquarters in Basel, Switzerland. Indigo will connect with growers directly to bring […]

Finance

uBiome Files Voluntary Chapter 11 Petitions to Accelerate an Orderly and Efficient Sale Process

September 11, 2019 Microbiome Times

uBiome, Inc., announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in Delaware to facilitate an orderly and efficient sale of its ongoing business, products in development, technology, and […]

Finance

UCI scientists awarded $2.7 million for soil nutrient microbiome research

September 2, 2019 Microbiome Times

A group of University of California, Irvine scientists believes a clue to withstanding climate change could be lurking in fields near their campus. Now the research team from UCI’s School of Biological Sciences and Department […]

Finance

Chr. Hansen and Lonza’s joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of LBPs

September 1, 2019 Microbiome Times

Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint […]

Finance

BiomX Announces In-house Phage Manufacturing Facility

August 28, 2019 Microbiome Times

BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, announced completion of construction of a new state-of-the-art manufacturing facility. The new facility is located at the company’s headquarters in Ness Ziona and […]

Posts navigation

« 1 … 21 22 23 … 32 »

Sign Up to Free Newsletter

QIAGEN WEBINAR SERIES – REGISTER HERE

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
    May 1, 2026
  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
sign up

Sign up to the Microbiome Times newsletter